NGF and Alzheimer disease: Furthermore, treatment with WGA-CL-NGF-CUR liposomes slightly increased the viability of SK-N-MC cells with Aβ 1-42, showing that WGA-CL-NGF-CUR liposomes can be potential colloidal delivery transporters in targeting the blood-brain barrier for AD treatment.